EP1734838A2 - Salzersatz mit biologisch kompatiblem polymer - Google Patents
Salzersatz mit biologisch kompatiblem polymerInfo
- Publication number
- EP1734838A2 EP1734838A2 EP05735736A EP05735736A EP1734838A2 EP 1734838 A2 EP1734838 A2 EP 1734838A2 EP 05735736 A EP05735736 A EP 05735736A EP 05735736 A EP05735736 A EP 05735736A EP 1734838 A2 EP1734838 A2 EP 1734838A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- salt
- food
- sodium
- drink
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000003839 salts Chemical class 0.000 title abstract description 57
- 229920000249 biocompatible polymer Polymers 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims abstract description 122
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 94
- 239000011780 sodium chloride Substances 0.000 claims abstract description 60
- 235000013305 food Nutrition 0.000 claims abstract description 58
- 235000011194 food seasoning agent Nutrition 0.000 claims abstract description 39
- 238000000034 method Methods 0.000 claims abstract description 32
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000011591 potassium Substances 0.000 claims abstract description 16
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 16
- 235000014659 low sodium diet Nutrition 0.000 claims abstract description 7
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 106
- 235000011164 potassium chloride Nutrition 0.000 claims description 53
- 239000001103 potassium chloride Substances 0.000 claims description 53
- 239000002202 Polyethylene glycol Substances 0.000 claims description 24
- 229920001223 polyethylene glycol Polymers 0.000 claims description 24
- 235000015193 tomato juice Nutrition 0.000 claims description 17
- 235000013365 dairy product Nutrition 0.000 claims description 15
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 12
- 235000013339 cereals Nutrition 0.000 claims description 11
- 235000013351 cheese Nutrition 0.000 claims description 9
- 235000011888 snacks Nutrition 0.000 claims description 9
- 239000006071 cream Substances 0.000 claims description 8
- 235000013372 meat Nutrition 0.000 claims description 8
- 235000013311 vegetables Nutrition 0.000 claims description 8
- 235000013399 edible fruits Nutrition 0.000 claims description 7
- 235000014347 soups Nutrition 0.000 claims description 7
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 235000002639 sodium chloride Nutrition 0.000 abstract description 114
- 239000011734 sodium Substances 0.000 abstract description 15
- 229910052708 sodium Inorganic materials 0.000 abstract description 15
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract description 12
- 235000015424 sodium Nutrition 0.000 abstract description 12
- 235000005911 diet Nutrition 0.000 abstract description 9
- 239000000796 flavoring agent Substances 0.000 abstract description 9
- 235000019634 flavors Nutrition 0.000 abstract description 9
- 230000037213 diet Effects 0.000 abstract description 4
- 235000015872 dietary supplement Nutrition 0.000 abstract description 2
- 235000019640 taste Nutrition 0.000 description 33
- 238000012360 testing method Methods 0.000 description 24
- 229920000642 polymer Polymers 0.000 description 20
- 239000000523 sample Substances 0.000 description 16
- 235000013575 mashed potatoes Nutrition 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 11
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 10
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 235000019643 salty taste Nutrition 0.000 description 9
- 239000000843 powder Substances 0.000 description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 235000019600 saltiness Nutrition 0.000 description 6
- 206010013911 Dysgeusia Diseases 0.000 description 5
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 5
- 235000019270 ammonium chloride Nutrition 0.000 description 5
- 230000000378 dietary effect Effects 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- -1 magnesium cations Chemical class 0.000 description 5
- 229910000160 potassium phosphate Inorganic materials 0.000 description 5
- 235000011009 potassium phosphates Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 235000013605 boiled eggs Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000012154 double-distilled water Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000014103 egg white Nutrition 0.000 description 4
- 210000000969 egg white Anatomy 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 229940118092 nulytely Drugs 0.000 description 4
- 235000015598 salt intake Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 239000005913 Maltodextrin Substances 0.000 description 3
- 229920002774 Maltodextrin Polymers 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 150000003841 chloride salts Chemical class 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229940035034 maltodextrin Drugs 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 235000021023 sodium intake Nutrition 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 2
- 239000004097 EU approved flavor enhancer Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000019264 food flavour enhancer Nutrition 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000016337 monopotassium tartrate Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- KYKNRZGSIGMXFH-ZVGUSBNCSA-M potassium bitartrate Chemical compound [K+].OC(=O)[C@H](O)[C@@H](O)C([O-])=O KYKNRZGSIGMXFH-ZVGUSBNCSA-M 0.000 description 2
- 229910001414 potassium ion Inorganic materials 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000013074 reference sample Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000015113 tomato pastes and purées Nutrition 0.000 description 2
- OHFNOQQJKQDEOT-UHFFFAOYSA-N 3-(3-methylphenyl)piperidine Chemical compound CC1=CC=CC(C2CNCCC2)=C1 OHFNOQQJKQDEOT-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- AANLCWYVVNBGEE-IDIVVRGQSA-L Disodium inosinate Chemical compound [Na+].[Na+].O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 AANLCWYVVNBGEE-IDIVVRGQSA-L 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000218737 Mycobacterium phage Power Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229920002562 Polyethylene Glycol 3350 Polymers 0.000 description 1
- 208000002787 Pregnancy Complications Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000013921 calcium diglutamate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- UMVAYAXXQSFULN-QHTZZOMLSA-L calcium;(2s)-2-aminopentanedioate;hydron Chemical compound [Ca+2].[O-]C(=O)[C@@H](N)CCC(O)=O.[O-]C(=O)[C@@H](N)CCC(O)=O UMVAYAXXQSFULN-QHTZZOMLSA-L 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- WDRWZVWLVBXVOI-QTNFYWBSSA-L dipotassium;(2s)-2-aminopentanedioate Chemical compound [K+].[K+].[O-]C(=O)[C@@H](N)CCC([O-])=O WDRWZVWLVBXVOI-QTNFYWBSSA-L 0.000 description 1
- CVOQYKPWIVSMDC-UHFFFAOYSA-L dipotassium;butanedioate Chemical compound [K+].[K+].[O-]C(=O)CCC([O-])=O CVOQYKPWIVSMDC-UHFFFAOYSA-L 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- PVBRXXAAPNGWGE-LGVAUZIVSA-L disodium 5'-guanylate Chemical compound [Na+].[Na+].C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP([O-])([O-])=O)[C@@H](O)[C@H]1O PVBRXXAAPNGWGE-LGVAUZIVSA-L 0.000 description 1
- 235000013890 disodium inosinate Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 235000021321 essential mineral Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000020803 food preference Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 235000013919 monopotassium glutamate Nutrition 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 229940100688 oral solution Drugs 0.000 description 1
- 229940081543 potassium bitartrate Drugs 0.000 description 1
- 235000019295 potassium fumarate Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 208000012113 pregnancy disease Diseases 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
- A23L27/45—Salt substitutes completely devoid of sodium chloride
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
Definitions
- the present invention relates to the fields of nutrition, diet, flavoring compositions and food products.
- the present invention relates to seasoning compositions, foods which contain such seasoning compositions, and methods for their respective formulations.
- salt as a taste and flavor enhancing agent is well known. In food processing, the preservative and organoleptic qualities of salt are well established and it is folly recognized that salt is attractive to the consumer (even when used in quantities deemed unhealthy).
- the total daily intake of salt in North America is estimated to be in the range of 10 to 12 grams. Salted snack foods account for a significant consumption of salt.
- table salt which contains sodium and chloride ions
- table salt use has been attributed to hypertension and other maladies.
- table salt use has been attributed to hypertension and other maladies.
- the medical community remains concerned over the extent of salt intake abuse and, accordingly, they advocate reducing salt intake.
- Doctors recommend reduction of dietary salt for those with many cardiac and renal conditions, particularly those associated with edema, hypertension, arteriosclerosis, pregnancy complications or epilepsy.
- dietary salt can cause the accumulation of fluids and a corresponding increase in the weight of the body tissues. It is known that it is the sodium in table salt that causes these deleterious effects. As a result, many individuals wish to limit their intake of sodium.
- Salt is, however, an important part of the taste sense or taste pattern of most people. Food without salt is often substantially tasteless, flat, and unpalatable. Thus, adhering to a low salt (or salt less) diet can negatively impact the pleasure of eating. Further, unpalatable food is not as easily ingested as that which is enjoyed.
- Ammonium chloride can also have a bitter after-taste, can disturb the acid-base balance in the blood, can produce acidosis, and can stimulate bronchial mucosa causing excess mucous secretion and coughing. Ammonium chloride must be eliminated by the body as urea, thus taxing the functions of the liver and the kidneys. Further, at cooking and baking temperatures, ammonium chloride can decompose thereby changing the pH value, taste and other properties of the food containing in which it is comprised.
- U.S. patents disclose and claim inventions relating to sodium-free substitutes.
- U.S. Pat. No. 2,471,144 issued to E. D. Davy and entitled “Salt Substitute” describes a sodium-free preparation containing chlorides of potassium and ammonium as the primary saline constituents (70-95% of the total ingredients), small amounts of calcium and magnesium cations, and citrate and formate anions. The small amounts of magnesium, calcium, formate and citrate ions are included in the preparation to "smooth out" the taste.
- U.S. Pat. No. 2,596,333 issued to A.
- Halpern et al and entitled “Dietary Salt Substitute,” describes potassium chloride particles (70-85% by weight) with a coating comprising an inert binder (gum or starch) and a glutamic acid compound (glutamic acid, potassium glutamate and calcium glutamate).
- the glutamic acid compound is used to mask the bitter taste of the potassium chloride particles.
- 2,824,008 entitled “Salt Substitute,” disclose a sodium-free composition comprising, by weight, 45-55 parts of potassium chloride, 30-40 parts of dipotassium succinate, and about 10-20 parts of dipotassium fumarate.
- the fumarate and succinate act to mask the bitter aftertaste usually accompanying the use of potassium chloride.
- a further sodium-free "Salt Substitute Composition" has been disclosed and claimed in U.S. Pat. No. 3,505,083 by H. C. Miller.
- the composition is comprised of about 80-99% by weight of potassium chloride and from about 1-20% by weight of fumaric acid.
- the bitter after-taste of potassium chloride is allegedly overcome by the fumaric acid component of the composition.
- a commercial version of this sodium-free composition is marketed by Morton Salt Company as "Morton Salt Substitute.”
- a low-sodium salt substitute contain between 50% and 70% by weight of potassium chloride, between 15% and 35% by weight of sugar, between 1% and 10% by weight of monocalcium glutimate, and up to 5% (based upon total weight of the salt substitute) of sodium chloride.
- U.S. Pat. Nos. 4,556,566; 4,556,567; and 4,556,568 teach compositions containing potassium chloride as a salt substitute wherein the potassium chloride comprises the core of the particle which is then coated with a maltodextrin ('567), a coating mixture of maltodextrin and sodium chloride ('566), and a coating mixture of maltodextrin, sodium chloride and cream of tartar (potassium bitartrate) ('568).
- Such potassium salt substitutes however, have been found to be unacceptable since they exhibit a bitter organoleptic taste when used and, thus, have not been fully effective at replacing sodium chloride.
- NuLYTELY ® is a composition comprising PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution. However, this composition is designed to induce diarrhea to rapidly cleanse the bowel. Accordingly, the relative amounts of the constituents are very different from the composition of the instant invention. For example, the amount of PEG used in NuLYTELY ® is 420 g. This amount is approximately 20 times greater the amount to be used daily in the salt substitute of the instant invention. NuLYTELY ® contains more sodium than potassium ( approximately 7.5 times higher). The ratio between PEG and KCl is 0.0035, more than 100 times lower than the approximate ratio desirable for the instant invention. KCl concentration after reconstitution of NuLYTELY ® in 4 liters of water is 0.037%, which is more than 100 times lower than the approximate concentration desired for complex formation in the instant invention.
- salt substitute which permits a consumer to reduce their salt intake without substantially changing the manner of applying salt and which tastes as salty as table salt yet contains less sodium content.
- Such a product ideally, would not change the organoleptic properties expected from salt, nor its manner of use, such as shaking, dipping or licking and so forth.
- the polymer is a polyethyleneglycol (PEG)-containing polymer.
- the invention provides compositions comprising a biocompatible uncharged polymer comprising an oxy or a hydroxyl group (for example, a (PEG)-containing polymer), sodium chloride (in sufficient amount to promote a normal salty taste) and potassium chloride (in sufficient amount to provide a protective effect against the toxicity of sodium).
- the composition would further comprise magnesium (in sufficient amount to mask or overcome the bitter taste of potassium and to supplement the otherwise low dietary supply of magnesium).
- the invention discloses ' palatable tablets or powders designed specifically for KCl supplementation. Because some patients are losing KCl, they need potassium as an essential mineral. As described above, KCl by itself has a terrible taste. Coated tablets (as described in the prior art) can cause problems by themselves.
- a dosage- form i.e., a powder or a tablet
- a biocompatible uncharged polymer comprising an oxy or a hydroxyl group (e.g., PEG) and KCl (or any other potasium salt) is therefore an advance over the formulations known in the art.
- the invention is generally drawn to a seasoning composition including potassium chloride and polyethylene glycol, wherein the potassium chloride and polyethylene glycol are present in a weight ratio from about 2: 1 to about 1 :4.
- the composition further comprises sodium chloride. In one aspect of this embodiment, the sodium chloride makes up between about 5 and 25% of the seasoning composition by weight. In another aspect of this embodiment, the composition further comprises magnesium chloride. Optionally, the magnesium chloride makes up about 2% of the seasoning composition by weight. In another aspect of this embodiment, the composition further comprises a cream. Optionally, this cream is a dairy product or a non-dairy product. In another embodiment of the seasoning composition, the composition further comprises magnesium chloride. In one aspect of this embodiment, the magnesium chloride makes up about 2% of the seasoning composition by weight. In another aspect of this embodiment, the composition further comprises a cream. Optionally, this cream is a dairy product or a non- dairy product.
- the polyethylene glycol has an average molecular weight of between 500 to 20,000.
- the invention is also generally drawn to a food or drink item comprising the above described seasoning composition.
- the food item is a member of the group consisting of meat, dairy products such as cheese, vegetables, fruits, grains, prepared foods and snack foods.
- the drink item is tomato juice or a soup.
- the invention is also generally drawn to a method of seasoning food or drink, said method comprising adding to said food or drink an effective amount of the above described seasoning composition.
- the food item is a member of the group consisting of meat, dairy products such as cheese, vegetables, fruits, grains, prepared foods and snack foods.
- the drink item is tomato juice or a soup.
- the seasoning composition is first dissolved in aqueous solution and then added to said food or drink.
- the food item is a member of the group consisting of meat, dairy products such as cheese, vegetables, fruits, grains, prepared foods and snack foods.
- the drink item is tomato juice or a soup.
- the invention is also generally drawn to a method for administering a low sodium diet to a patient in need thereof comprising the administration of the above described seasoning composition.
- the seasoning composition is first added to food or drink and then administered to the patient.
- the food item is a member of the group consisting of meat, dairy products such as cheese, vegetables, fruits, grains, prepared foods and snack foods.
- the drink item is tomato juice or a soup.
- the invention is also generally drawn to a method for administrating potassium orally, in a palatable form, to a patient in need thereof comprising the administration of the above described seasoning composition.
- the seasoning composition is first added to food or drink and then administered to the patient.
- the food item is a member of the group consisting of meat, dairy products such as cheese, vegetables, fruits, grains, prepared foods and snack foods.
- the drink item is tomato juice or a soup. Additional embodiments disclose methods of making the inventive compositions, foodstuffs comprising such compositions, and methods for administering a low sodium diet to a patient in need of such comprising the administration of foods comprising the compositions.
- a surprising and unexpected taste result has been discovered with respect to low-sodium salt substitute compositions. Specifically, the addition of a biocompatible uncharged polymer comprising an oxy or a hydroxyl group to a composition comprising, for example, potassium chloride and sodium chloride, results in an enhancement of the salty flavor of the composition while the unpleasant taste of potassium chloride is being eliminated. Accordingly, less sodium can be used in the composition without sacrificing the salty taste.
- the types of available polymers would include such biocompatible uncharged polymers, whether the polymers are natural or synthetic.
- PEG is clearly an example of such a synthetic polymer and Ficoll and Dextran are examples of natural polymers.
- the molecular weight of the PEG would range from about 500 to 20,000 Daltons.
- the addition of such polymers may be utilized to enhance the salty flavor of many of the prior art "low salt" compositions, while avoiding additional unpleasant tastes, particularly when such formulations comprise potassium chloride or sodium chloride.
- This unexpected and unpredictable taste effect for the proposed low-sodium composition results in a significant reduction of the amount of sodium intake via the composition as compared to the sodium intake for table salt where the desired saltiness taste effect or level is constant.
- the invention relates to compositions for enhancing the pleasant salty flavor of foods.
- the invention relates to methods for enhancing the pleasant salty flavor of foods through use of the inventive compositions.
- the invention relates to methods for administering a low sodium diet to a patient in need thereof.
- compositions of the present invention may be prepared by thoroughly mixing the components until a homogeneous product is attained. Accordingly, the proposed low-sodium salt substitute composition may look, pour, repose, store and taste like table salt.
- Low-sodium salt substitutes of the present invention can be added to a wide variety of foods in flavor-enhancing amounts.
- a flavor-enhancing amount depends on the particular taste of the user, the particular food and the particular effect desired.
- the amount of salt in foodstuffs varies from about 0.5% to about 4% by weight.
- salt or salt substitutes are added in amounts of from about 0.5% to about 1% by weight of the food.
- the low-sodium salt substitute and dietary supplement of the present invention can be added to any foodstuff where a salty taste is desired or expected, such as cheese, mashed potatoes, juices, vegetables, meat, poultry, fish, snack foods and the like.
- the invention relates to a composition capable of imparting a salty taste, the composition comprising a biocompatible uncharged polymer comprising an oxy or a hydroxyl group.
- the invention relates to a composition capable of imparting a salty taste, the composition comprising a potassium salt and a biocompatible uncharged polymer comprising an oxy or a hydroxyl group.
- the invention relates to a composition according to the instant invention, wherein the polymer is a polyethylene glycol-containing polymer.
- the invention relates to a composition according to the instant invention, wherein the polymer is a polysaccharide.
- the invention relates to a composition according to the instant invention, wherein the polysaccharide is dextran or dextrin.
- the invention relates to a composition according to the instant invention further comprising a dairy or non-dairy cream.
- the invention relates to a composition according to the instant invention further comprising a sodium salt. In another embodiment, the invention relates to a composition according to the instant invention, wherein further comprising a magnesium salt
- a complex exists between potassium ions and the polymer.
- a concentrated aqueous solution comprising the polymer and the potassium ions are prepared.
- the concentration of each of the typical constituents of the complex, PEG and KCl should be at least about 4% and preferably at least about 10%.
- This aqueous solution can be made even more concentrated by the evaporation of water and can be further dried to a solid state that is then ground to powder. Accordingly, in this embodiment, one should first form the complex and then convert it to a powder.
- the concentrated solution of the complex can be used as such (without drying it completely).
- a concentrated solution of the complex is especially useful, for example, in the preparation of cheese.
- the concentration of sodium should be significantly lower than that of the potassium chloride.
- the concentration of NaCl should be less than about 50% of the concentration of KCl.
- the concentration of NaCl should be less than about 25% of the KCl concentration.
- the concentration of NaCl should be less than about 10% of the KCl concentration.
- the weight ratio between the polymer and the KCl in the complex is formulated to be in the range of about 0.2:1.0 to about 20:1 ofPEG:KCl. Accordingly, 1:5, 1:4, 1:3, 1:2, 1:1, 2:1, 3:1, 4:1, 5:1, 6:1, 7:1, 8:1, 9:1, 10:1, 11:1, 12:1, 13:1, 14:1, 15:1, 16:1, 17:1, 18:1 and 19:1 would all be acceptable weight ratios.
- the invention relates to a food item comprising the inventive composition.
- the composition is in a dry form. In another aspect, the composition is in a wet form.
- the invention relates to a method for administering a low sodium diet to a patient in need thereof comprising the administration of the inventive composition.
- the invention relates to a method for administrating potassium orally, in a palatable form, to a patient in need thereof comprising the administration of the inventive composition comprising potassium.
- Example 1 Preparation of a salt substitute containing PEG and KC 6 g of PEG (average molecular weight 3,500) plus 3 g KCl were dissolved in 50 ml double distilled water and let dry in a flat vessel, at 37° C.
- Example 2 Preparation of a salt substitute containing PEG, KCl and 6.6% NaCl.
- Example 3 Preparation of a salt substitute containing PEG, KCl, MgCl and 8% NaCl.
- Example 4 Preparation of a salt substitute containing PEG, KCl and MgCl , without NaCl.
- Example 5 The low-sodium salt substitute composition of the present invention is preferable to commercially available table salt in commercial instant mashed potatoes.
- a low-sodium salt substitute composition in accordance with the present invention is subjected to paired preference and paired comparison (saltiness) taste testing by a panel of 40 untrained judges.
- the inventive composition is compared against a commercially available salt in the well accepted test medium of mashed potatoes.
- the commercially available salt (Morton's iodized salt) in the mashed potato composition constitutes the "reference sample.”
- the low-sodium salt substitute composition in a like mashed potato composition constitutes the "test sample.”
- Betty Crocker brand potato buds are then used to prepare the mashed potato samples for taste evaluation.
- Each treatment of mashed potatoes contains four cups of de-ionized water, two cups of milk (3.2% minimum fat, homogenized, pasteurized), and four cups of potato buds. No butter or margarine is used.
- sodium chloride treatment reference samples
- the reference treatment of mashed potatoes is made according to the following directions: heat the water, milk and salt as a mixture to boiling; remove the mixture from heat and stir in potato buds until just moistened; let stand until liquid is absorbed (about 30 seconds); and whip with fork until desired consistency.
- the reference treatment of mashed potatoes is held over a steam table to keep warm during the time required to serve.
- the test treatment of mashed potatoes containing the low-sodium salt substitute composition is prepared in a like manner.
- the paired preference and paired comparison (saltiness) taste testing by the 40 panelists is conducted in accordance with ASTM standard recommended practices for sensory evaluation of food products. All reference and test samples of mashed potatoes are coded and not otherwise identified to the panelists. For the paired preference test, a majority of the panelists will prefer the "test sample” (mashed potatoes containing the low-sodium salt substitute composition of the invention). For the paired comparison test, a majority of the judges will find the low-sodium test sample to be "more salty.
- Example 6 The low-sodium salt substitute of the present invention is preferable to commercially available table salt in tomato juice .
- a low-sodium salt substitute composition in accordance with the present invention is subjected to consumer acceptance taste testing for "saltiness flavor" and for "overall desirability," by a panel of 35 untrained judges, with respect to commercially available salt in the well accepted test medium of tomato juice.
- the commercially available salt (Morton's iodized salt) in the tomato juice composition constitutes the "reference sample.”
- the low sodium salt substitute composition of the instant invention is placed in a like tomato juice composition and constitutes the "test sample.”
- Unsalted tomato juice samples are prepared by mixing unsalted S & W brand tomato puree with de-ionized water in a ratio of 1 part tomato puree to 3 parts water.
- For the sodium chloride treatment 1% by weight of the iodized salt is mixed into the prepared unsalted tomato juice.
- test samples 1% by weight of the low-sodium salt substitute composition is mixed into the prepared unsalted tomato juice. All reference and test samples of tomato juice are coded and not otherwise identified to the panelists.
- Acceptance testing of the test samples versus the reference samples is based upon the rating of samples on the "Hedonic" scale as described by D. R. Peryam and F. J. Pilgram ("Hedonic Scale Method of Measuring Food Preferences," Food Technology, 11(9); 9-14, (1957), hereby incorporated by reference).
- the Hedonic scale equates the numerical values 1-9 to successive scale points at the "dislike" end of the scale to the "like” end of the scale.
- the samples (reference and test) are rated by each panelist or judge and “mean ratings" for the samples are developed and compared statistically.
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Seasonings (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55379604P | 2004-03-15 | 2004-03-15 | |
| US57798004P | 2004-06-07 | 2004-06-07 | |
| PCT/IB2005/001338 WO2005086566A2 (en) | 2004-03-15 | 2005-03-14 | Salt substitute comprising biocompatible polymer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1734838A2 true EP1734838A2 (de) | 2006-12-27 |
Family
ID=34976013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP05735736A Withdrawn EP1734838A2 (de) | 2004-03-15 | 2005-03-14 | Salzersatz mit biologisch kompatiblem polymer |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1734838A2 (de) |
| AU (1) | AU2005220642A1 (de) |
| CA (1) | CA2559601A1 (de) |
| IL (1) | IL178063A0 (de) |
| WO (1) | WO2005086566A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070059428A1 (en) | 2005-09-14 | 2007-03-15 | Chigurupati Sambasiva R | Low-sodium salt composition |
| US9629384B2 (en) | 2005-09-14 | 2017-04-25 | S & P Ingredient Development, Llc | Low sodium salt composition |
| US8802181B2 (en) | 2006-10-05 | 2014-08-12 | S & P Ingredient Development, Llc | Low sodium salt composition |
| US7854956B2 (en) | 2007-03-07 | 2010-12-21 | Exportadora De Sal, S.A. De C.V. | Low sodium salt compositions and methods of preparation and uses thereof |
| ES2331553B1 (es) * | 2008-05-30 | 2010-10-14 | Marta Eugenia Rodriguez De La Torre | Sal afrutada. |
| US9247762B1 (en) | 2014-09-09 | 2016-02-02 | S & P Ingredient Development, Llc | Salt substitute with plant tissue carrier |
| CA3075623C (en) | 2017-09-18 | 2023-11-14 | S & P Ingredient Development, Llc | Low sodium salt substitute with potassium chloride |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1971910A (en) * | 1931-03-02 | 1934-08-28 | Griffith Laboratories | Solid flavoring composition |
| US2385412A (en) * | 1943-05-03 | 1945-09-25 | Griffith Laboratories | Capsicum-containing seasoning composition |
-
2005
- 2005-03-14 EP EP05735736A patent/EP1734838A2/de not_active Withdrawn
- 2005-03-14 CA CA002559601A patent/CA2559601A1/en not_active Abandoned
- 2005-03-14 WO PCT/IB2005/001338 patent/WO2005086566A2/en not_active Ceased
- 2005-03-14 AU AU2005220642A patent/AU2005220642A1/en not_active Abandoned
-
2006
- 2006-09-13 IL IL178063A patent/IL178063A0/en unknown
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2005086566A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005086566A2 (en) | 2005-09-22 |
| AU2005220642A1 (en) | 2005-09-22 |
| WO2005086566A3 (en) | 2006-03-02 |
| CA2559601A1 (en) | 2005-09-22 |
| IL178063A0 (en) | 2006-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1210635A (en) | Low-sodium salt substitute | |
| US4243691A (en) | Sodium-free salt substitute | |
| CN106220546B (zh) | 作为食品加香化合物的n-酰基脯氨酸衍生物 | |
| US7402328B2 (en) | Stable sodium-free or low-sodium aqueous solution of agreeable saltiness taste | |
| CN103153091B (zh) | 饮食物的盐味改善方法、饮食物以及盐味改善剂 | |
| US5871803A (en) | Salt flavor enhancing compositions, food products including such compositions, and methods for preparing such products | |
| CN101467691B (zh) | 食品中的钾强化 | |
| US20120201945A1 (en) | Food composition with reinforced or enhanced salty taste and composition containing potassium chloride with suppressed offensive taste | |
| CN100346725C (zh) | 稳定和具有生物可利用性的铁强化饮料 | |
| Homler | Aspartame: Implications for the food scientist | |
| CN104219965A (zh) | 作为食品加香化合物的γ氨基-丁酸和β丙氨酸的N-酰基衍生物 | |
| JP2010521974A (ja) | 苦味のないナトリウム不含または低ナトリウム塩組成物 | |
| US8999425B2 (en) | Low sodium salt substitute compositions | |
| JP2003500077A (ja) | 無機質の味を遮蔽するための方法及び組成物 | |
| JP2008510469A (ja) | トレハロースを含む成分系、トレハロースを含む食品、およびこれらを作製する方法 | |
| WO2005086566A2 (en) | Salt substitute comprising biocompatible polymer | |
| EP2030512A1 (de) | Geschmacksverbesserer | |
| JP2007209268A (ja) | 飲料、冷菓、デザート、菓子、惣菜及びその他加工品を含む食品全般に渡る呈味改良 | |
| JP2920434B2 (ja) | カルシウム及び食物繊維含有飲食物とその製造方法 | |
| JP2001346556A (ja) | 果実酸を含有する飲料 | |
| US4288464A (en) | Flavor enhancer | |
| JPH09168378A (ja) | 栄養組成物 | |
| CN106631943B (zh) | 作为食品加香化合物的n-酰化甲硫氨酸衍生物 | |
| WO2013103593A1 (en) | Low sodium salt substitute compositions | |
| JP2004536601A (ja) | 料理調合物と方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20061013 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20091001 |